The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,028.00
Bid: 12,012.00
Ask: 12,016.00
Change: -268.00 (-2.18%)
Spread: 4.00 (0.033%)
Open: 12,226.00
High: 12,266.00
Low: 11,988.00
Prev. Close: 12,296.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-EU rejects accusations of 'vaccine nationalism'

Tue, 09th Mar 2021 15:41

(Adds Michel comment on UK reaction)

By John Chalmers and Kate Abnett

BRUSSELS, March 9 (Reuters) - European Council President
Charles Michel on Tuesday rejected charges of "vaccine
nationalism" levelled against the EU, saying that while Britain
and the United States have outright bans on exports of COVID-19
shots, the EU had not stopped exporting.

The EU has found itself under fire at home for a vaccine
roll-out much slower than those of former member Britain or the
United States, and abroad for so far doing less than China,
Russia or India to supply vaccines to poor countries.

Last week it annoyed vaccine buyers abroad by endorsing an
Italian decision to halt a shipment to Australia.

Britain had a quick retort for the comments by Michel, who
represents the 27 European Union member states, saying it has
not blocked the export of a single COVID-19 vaccine.

"Any references to a UK export ban or any restrictions on
vaccines are completely false," a UK government spokesman said.

Britain's foreign minister Dominic Raab has written to
Michel to "set the record straight" and a representative of the
EU's delegation to the UK has been summoned to a meeting at the
Foreign Office, officials confirmed.

"Glad if the UK reaction leads to more transparency &
increased exports, to EU and third countries," Michel said in a
tweet on Tuesday evening.

The dispute arose after Michel published a lengthy statement
on Tuesday afternoon defending the bloc's strategy. He said that
without Europe, it would not have been possible to develop and
produce several vaccines in less than a year, and EU solidarity
had ensured that poorer countries of the bloc received their
first doses.

He took aim at the "highly publicised" supply of vaccines by
China and Russia to other countries.

"We should not let ourselves be misled by China and Russia,
both regimes with less desirable values than ours, as they
organise highly limited but widely publicised operations to
supply vaccines to others." Michel also noted that China and
Russia had both vaccinated fewer people at home than the EU.

"Europe will not use vaccines for propaganda purposes. We
promote our values," he said.

Michel also defended a system to control the export of doses
produced in EU countries, invoked by Italy last week to block a
shipment of AstraZeneca shots to Australia.

"Our objective: to prevent companies from which we have
ordered and pre-financed doses from exporting them to other
advanced countries when they have not delivered to us what was
promised," Michel said. "The EU has never stopped exporting."

He said the EU would become the world's leading vaccine
producer in the coming months and was the best equipped to adapt
vaccine output quickly to virus mutations.

Tensions have increased between London and Brussels
following the completion of Britain's exit from the EU at the
end of 2020.

Relations strained by years of bruising talks over Brexit
took a turn for the worse in January when the EU briefly
threatened to use emergency measures to stop coronavirus
vaccines going from the bloc into Northern Ireland, a
British-ruled province bordering EU member state Ireland.
(Additional reporting by Kate Abnett in Brussels, Elizabeth
Piper and Costas Pitas in London; Editing by Mark Heinrich,
Sonya Hepinstall and Dan Grebler)

More News
Today 07:02

AstraZeneca experimental lung cancer drug shows promising results

(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant said on Tuesday.

Read more
27 May 2024 07:49

IN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXd

AstraZeneca PLC - Cambridge, UK-based pharmaceutical firm - Alongside Japan's Daiichi Sankyo Co Ltd, notes positive data for datopotamab deruxtecan in phase III trial on lung cancer. Says the treatment, also known as Dato-DXd, showed a clinically meaningfully improvement in overall survival versus chemotherapy in advanced nonsquamous non-small cell lung cancer. The results build upon the positive progression-free survival findings presented back in 2023, Astra adds.

Read more
22 May 2024 09:53

LONDON BROKER RATINGS: Barclays cuts NextEnergy but lifts JLEN

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
22 May 2024 02:00

British firms expecting hard time in China market, lobby group warns

BEIJING, May 22 (Reuters) - British firms expect doing business in China to become harder over the next five years, a British business lobby group said on Wednesday, as Beijing strives to halt a retreat in foreign funds from a market once seen as the engine of global growth.

Read more
21 May 2024 19:00

Sector movers: Stocks slip amid light profit-taking

(Sharecast News) - Stocks ended a tad lower as investors waited on a raft of US central bank speakers scheduled for after the close of markets in London.

Read more
21 May 2024 17:20

Europe's STOXX 600 ends lower as rate uncertainty prevails

Focus on Fed minutes, Nvidia earnings

*

Read more
21 May 2024 17:04

LONDON MARKET CLOSE: London dips as eyes turn to UK inflation reading

(Alliance News) - Stock prices in London closed in the red on Tuesday, as investors nervously eye a key UK inflation reading, which could prompt the Bank of England to consider interest rate cuts.

Read more
21 May 2024 15:00

London close: Stocks fall ahead of key inflation reading

(Sharecast News) - London stocks ended in negative territory on Tuesday, influenced by the latest UK economic outlook from the International Monetary Fund (IMF) and comments from US Federal Reserve officials.

Read more
21 May 2024 12:03

CORRECT: Stocks fall but pound up as IMF ups UK forecast

(Correcting London Stock Exchange index prices.)

Read more
21 May 2024 12:00

LONDON MARKET MIDDAY: Stocks fall but pound up as IMF ups UK forecast

(Alliance News) - Stock prices in Europe were lower heading into Tuesday afternoon, with shares in New York also set for a muted open, as a recent rally for equities takes a pause.

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 09:04

LONDON MARKET OPEN: FTSE 100 declines after Asian stocks fall

(Alliance News) - Stock prices in London opened in the red on Tuesday, with some US interest rate cut optimism cooling after hawkish words from Federal Reserve central bankers.

Read more
21 May 2024 08:18

TOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aim

(Alliance News) - AstraZeneca PLC on Tuesday set out its ambition to achieve USD80 billion in annual revenue by the end of the decade as it signalled a new "era of growth."

Read more
21 May 2024 07:52

LONDON BRIEFING: AstraZeneca plots "new era of growth"; SSP confident

(Alliance News) - London's FTSE 100 is called to open lower on Tuesday, following a mixed close in New York overnight, and tepid trade in Asia.

Read more
21 May 2024 07:34

AstraZeneca lays out plans to hit $80bn in revenues by 2030

(Sharecast News) - AstraZeneca has unveiled medium-term growth targets to nearly double group revenues by the end of the decade as it predicts significant growth from existing oncology, biopharmaceuticals and rare disease portfolios.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.